Nosocomial and community infections due to class A extended-spectrum β-lactamase (ESBlA)-producing Escherichia coli and Klebsiella spp. in southern Brazil

Brazilian Journal of Infectious Diseases

Volumn 15, Issue 2, 2011, Pages 138-143

  Wollheim, Claudia ^a   Guerra, Ivani Maria F ^a   Conte, Vania D ^a   Hofman, Sheila P ^a   Schreiner, Fernando J ^a   Delamare, Ana Paula L ^a   Barth, Afonso L ^b   Echeverrigaray, Sérgio ^a   Da Costa, Sérgio Olavo P ^a  

^a UNIVERSITY OF CAXIAS DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Bacterial typing techniques; Polymerase chain reaction; lactamases

Indexed keywords

AMIKACIN; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLASS A EXTENDED SPECTRUM BETA LACTAMASE; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GATIFLOXACIN; GENTAMICIN; NITROFURANTOIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM CONJUGATION; BACTERIUM ISOLATE; BETA LACTAMASE CTX M GENE; BETA LACTAMASE SHV GENE; BETA LACTAMASE TEM GENE; BRAZIL; CATHETER INFECTION; CHILD; CLONAL VARIATION; COMMUNITY SAMPLE; CONTROLLED STUDY; DISK DIFFUSION; ESCHERICHIA COLI INFECTION; FEMALE; GENE TRANSFER; GENETIC VARIABILITY; GENOTYPE; HOSPITAL INFECTION; HUMAN; INFANT; INTENSIVE CARE UNIT; KLEBSIELLA INFECTION; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE INFECTION; MAJOR CLINICAL STUDY; MALE; NEWBORN INTENSIVE CARE; PERITONEAL FLUID; POLYMERASE CHAIN REACTION; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; RESPIRATORY TRACT INFECTION; SEX DIFFERENCE; SKIN INFECTION; SOFT TISSUE INFECTION; URINARY TRACT INFECTION; WARD;

EID: 79959624040     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1590/S1413-86702011000200008     Document Type: Article

References (30)

1. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 2005; 18:657-86.
2. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemothey 1995; 39:1211-33.
3. Giske CG, Sundsford AS, Kahlmeter G et al. Redefning extended-spectrum β-lactamase: balancing science and clinical need. J Antimicrob Chemother 2009; 63:1-4.
4. Jacoby GA, Walsh KE, Walker VJ. Identification of extended-spectrum, AmpC, and carbapenem-hydrolyzing β-lactamases in Escherichia coli and Klebsiella pneumoniae by disk tests. J Clin Microbiol 2006; 44:1971-6.
5. Mena A, Plasencia V, García L et al. Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development. J Clin Microbiob2006; 44:2831-7.
6. Rahal JJ. The role of carbapenems in initial therapy for serious Gram-negative infectious. Critical Care 2008; (12):2-7.
7. Poirel L, Decousser J W, Nordmann, P. Insertion sequence ISEcp1B is involved in expression and mobilization of the blaCTX-M β-lactamase gene. Antimicrob Agents Chemother 2003; 47:2938-45.
8. Machado E, Cantón R, Baquero F et al. Integron content of extended-spectrum-β-lactamase-producing Escherichia coli strains over 12 years in a single hospital in Madrid, Spain. Antimicrob Agents Chemother 2005; 49:1823-9.
9. Slama TG. Gram-negative antibiotic resistance: there is a price to pay. Critical Care 2008; 12:S4.
10. Paterson DL, Ko W-C, Gottberg A Von et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum β-lactamase production in nosocomial infections. Ann Intern Med 2004; 140:26-32.
11. Garcia DO, Doi Y, Szabo D et al. Multiclonal outbreak of Kleb-siella pneumoniae producing extended-spectrum β-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil. Antimicrob Agents Chemother 2008; 52:1790-3.
12. Knothe H, Shah P, Kramery V et al. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983;11:315-7.
13. st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14:933-51.
14. Paterson DL, Hujer KM, Hujer AM et al. Extended-spectrum β-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type β-lactamases. Antimicrob Agents Chemother 2003; 47:3554-60.
15. Rodriguez-Baño J, Navarro MD, Romero L et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in non-hospitalized patients. J Clin Microbiol 2004; 42:1089-94.
16. Oteo J, Navarro C, Cercenado E et al. Spread of Escherichia coli strains with high-level cefotaxime and cefazidime resistance between the community, long-term care facilities and hospital institutions. J Clin Microbiol 2006; 44:2359-66.
17. Mendonça N, Leitão J, Manageiro V et al. Antimicrobial Resistance Surveillance Program in Portugal; Caniça, M. Spread of extended-spectrum β-lactamase CTX-M-producing Es-cherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrob Agents Chemother 2007; 51:1946-55.
18. Garner JS, Jarvis WR, Emori TG et al. CDC defnitions isolated for nosocomial infections. Am J Infect Control 1988; 16:128-40.
19. Rodriguez-Baño, J, Navarro, MD, Romero, L et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in non-hospitalized patients. J Clin Microbiol 2004; 42:1089-94.
20. Clinical and Laboratory Standards Institute. (CLSI). Performance standards for antimicrobial disk susceptibility testing. Approved standard M2-A10. Clinical Laboratory Standards Institute, Wayne, PA, 2007.
21. Centers for Disease Control and Prevention. One-Day (24-28 h) Standardized Laboratory Protocol for Molecular Subtyping of Escherichia coli O157:H7, non-typhoidal Salmonella sero-types, and Shigella sonnei by Pulsed Field Gel Electrophoresis. In: PulseNet PFGE Manual http://www.cdc.gov/PulseNet/protocols/ecoli_salmonella_shigella_protocols.pdf.
22. Tenover F, Arbeit R, Goering R et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-feld gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-39.
23. Coque TM, Liver A, Pérez-Dias JC et al. Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum β-lactamase are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000). Antimicrob Agents Chemother 2002; 46:500-10.
24. Winokur PL, Canton R, Casellas JM et al. Variations in the prevalence of strains expressing an extended-spectrum β-lactamases phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infec Dis 2001; 32:94-103.
25. Sader, HS, Gales, AC, Pfaller, MA et al. Pathogens frequency and resistance patterns in Brazilian hospitals: summary of results from three years of SENTRY antimicrobial surveillance program. Braz J Infect Dis 2001; 59:200-14.
26. Minarini LA, Gales AC, Palazzo IC et al. Prevalence of community-occurring extended spectrum β-lactamase-producing Enterobacteriaceae in Brazil. Curr Microbiol 2007; 54:335-41.
27. Nicolas-Chanoine, MH, Blanco, J, Lefon-Guibout, V et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008; 61:273-81.
28. Romero, L, López, L, Rodrigues-Baño, L et al. Long-term study of the frequency of Escherichia coli and Klebsiella pneu-moniae isolates producing extended-spectrum β-lactamases. Clin Microbiol Infect 2005; 11:625-31.
29. Canton R, Coque TM. The CTX-M β-lactamase pandemic. Curr Opin Microbiol 2006; 466-75.
30. Lewis JS, Herrera M, Wickers B et al. First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ES-BLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob Agents Chemother 2007; 51:4015-21.